NCT06155188View on ClinicalTrials.gov

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 29, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
LeukemiaStem Cell TransplantCord Blood
Interventions
PROCEDURE

applying of FLU+CY post-HSCT

The conditioning regimen (PT-Cy/Flu group) consisted of fludarabine (40mg/m2, d-5 to d-3 and d+3, d+4), busulfan (100mg/m2, d-6 to d-3), haplo-PBSC (d0), PTCy (50mg/kg, d+3, d+4) and UCB (d+6).

Trial Locations (1)

510515

RECRUITING

Nanfang Hospital, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER